MLZ Conference: Neutrons for Health

Session

Oral presentations V

29 Jun 2017, 09:00

65. A brief history of the evolution of carrier-free Lutetium-177 into a globally established isotope platform for a new class of targeted cancer therapeutics

Oliver Buck (ITM Isotopen Technologien München AG)

29/06/2017, 09:00

Keynote

68. Nanotechnology-based Drug Delivery in Oncology - Targeted Chemotherapy and Examples for specific Radioenhancement

Rainer Tietze (Universitätsklinikum Erlangen)

29/06/2017, 10:40

Keynote

67. Neutron activation of QuiremSpheres® in FRM II

Johannes Nijsen (Quirem Medical)

29/06/2017, 09:50

Contributed

70. Neutron radiobiology experiments at ILL for improving Boron Neutron Capture Therapy

Ignacio Porras (Universidad de Granada)

29/06/2017, 11:30

Contributed

66. Production of Mo-99/Tc-99m at FRM II - Status of the Project

Heiko Gerstenberg (FRM II, TUM)

29/06/2017, 09:30

Contributed

69. Target Nanoparticles for Cancer Therapy with Neutrons and Photons

Thomas Nawroth (Gutenberg-University, Pharmaceutical Technology)

29/06/2017, 11:10

Contributed